Product Code: RP-ID-10336496 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10336496
Market Overview:
Global Dual Chamber Prefilled Syringes Market Size study, by Material (Glass and Plastic), Indication (Hemophilia, Schizophrenia, Endometriosis, Erectile Dysfunction, and Diabetes), Application (Liquid/Powder, Liquid/Liquid) and Regional Forecasts 2020-2027
Global Dual Chamber Prefilled Syringes Market is valued approximately USD 121 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.20% over the forecast period 2020-2027. Dual chamber injectors and syringes are health devices used to store active pharmaceutical components or biological substances (such as tissue, blood or serum) that are not stable for lengthy period. These devices aid to maintain sterility of drugs before the time of injection to evade drug loss. For example, liquid proteins drugs need refrigeration before dispensing. Thus, dual chamber injectors and syringes benefits to manage proper storage condition of these drugs as proper storage of these drugs reduces the adverse effects of drug delivery. The Advancement in technology which introduces improved arrangement for liquid components in injectors drives the market growth. Also, the growing biopharmaceutical industry along with advanced manufacturing processes and integration of companies fuels the market growth. As in May 2020, Evonik announced to invest USD 27 million targeted to increase its active pharmaceutical ingredient and production capacity in Germany. While, in March 2019, Gerresheimer announced the establishment for a new plant in North Macedonia. The plant is targeted to manufacture plastic systems such as prefilled syringes. Increasing adoption of ready-to-use elastomeric syringe components by drug manufacturers is a key trend observed in the prefilled syringes market. However, risk of cross contamination impedes the growth of the market over the forecast period of 2020-2027. Although, tremendous research in order to make separable dual chamber syringes cost effective presents a lucrative opportunity for the market.
The regional analysis of global Dual Chamber Prefilled Syringes market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the well established healthcare industry and rapid adoption of new technology and devices in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising disposable income, rising population would create lucrative growth prospects for the Dual Chamber Prefilled Syringes market across Asia-Pacific region.
Major market player included in this report are:
Nipro Corporation
Gerresheimer AG
Vetter Pharma
Credence Medsystems
Arte Corporation
Pfizer Inc.,
AstraZeneca Plc.,
Maeda Industry Co., Ltd
Bristol-Myers Squibb Company
Novartis AG
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Material:
Glass
Plastic
By Indication:
Hemophilia
Schizophrenia
Endometriosis
Erectile Dysfunction
Diabetes
By Application:
Liquid/Powder
Liquid/Liquid
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Dual Chamber Prefilled Syringes Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Nipro Corporation
Gerresheimer AG
Vetter Pharma
Credence Medsystems
Arte Corporation
Pfizer Inc.,
AstraZeneca Plc.,
Maeda Industry Co., Ltd
Bristol-Myers Squibb Company
Novartis AG
Related Reports
Proof of Quality & Reliability
